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licenseDid self-sampling improve the adherence to group B streptococci
screening in pregnant women?More than 25% of pregnant women may have vaginal or
rectal colonization of Streptococcus agalactiae, known as
Group B streptococcus (GBS), which is a leading infectious
cause of neonatal morbidity and mortality.1e3 However, a
recent case series from the Active Bacterial Core surveillance
system concluded that optimal implementation of the Centers
for Disease Control and Prevention (CDC) guidelines could
reduce the rate by 26e59%, with prenatal screening and
intrapartum prophylaxis being the most common error
types.4,5 Therefore, the attitudes and practice patterns of
obstetricians related to various aspects of screening for GBS
colonization, and providing intrapartum antibiotics prophy-
laxis against early-onset neonatal GBS infection could be
several of the most important factors associated with further
reduction of the GBS disease burden.
The study by Ko et al6 in this issue of the Journal of
Chinese Medical Association, entitled A questionnaire study
on the acceptability of self-sampling versus screening by
clinician for Group B streptococcus (GBS) investigated 327
pregnant women attending an antenatal clinic for GBS
screening. The results of their study showed that in excess of
60% of pregnant women preferred screening by a healthcare
worker, and only 5.6% preferred self-screening. The reasons
were based on their belief that these professionals had some
greater extent of knowledge, and thus might provide a more
believable GBS screening procedure.6 In fact, these respond-
ents were primarily worried about the accuracy of self-
screening for GBS.6 However, it is interesting to find that if
these respondents have the opportunity to get pregnant again,
nearly 70% would like to undertake self-screening for GBS
screening. Additionally, nearly 60% of these respondents
would also recommend to others that they do the GBS self-
screening procedures.6 Although the results of this study
raise certain questions, based on the relative inconsistency of
the study population number provided by the authors in their
article (the number of participants was different in all tables),6
this article is interesting and worthy of further discussion.
Self-sampling may be an excellent strategy to overcome the
obstacle of a large scale population screening and/or health-
promoting policy. The authors provided this idea for thex.doi.org/10.1016/j.jcma.2015.08.007
901/Copyright © 2015, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).purpose of promoting global health and increasing GBS screen-
ing in pregnant women, so it is welcome. However, does it really
work? Is it really practical? Some arguments need to be raised.
In Taiwan, Papanicolaou (Pap) smear may be one of the
most successful screening methods used to fight invasive
cervical cancer,7,8 and the incidence of invasive cervical
cancer has dramatically declined in recent years.9 In the past,
cervical cancer was the most common cancer associated with
the female reproductive organs. Now, however, the incidence
of breast cancer and endometrial cancer has increased to such
an extent that they surpass that of cervical cancer.10 The
decreased incidence of cervical cancer is partly due to the
widespread use of Pap smear. Although the introduction of Pap
smear was successful, the frequency of Pap smear screening
remains low, with a reported rate of use of the triennial Pap of
35% for women aged 40e69 years in 1997, 56% in 2001 and
reaching a plateau of 55% in 2010 and after.11 There are many
articles available that focus on the reasons underlying a low
frequency rate of Pap smear in Taiwan, and many strategies
have been tried to improve the cervical cancer screening
rate.11,12 Although many possible explanations could explain
the causes, one of the likely reasons might be secondary to
traditional embarrassment to expose female genital organs.
One report showed several barriers to cervical cancer screen-
ing, including worry, embarrassment, stigma, the lack of
female physicians,12 which all make women hesitate or
decline to receive cervical cancer screening. Therefore, the
finding from the study by Ko et al6 showing the potential value
of self-sampling from the female genital tract attracted our
attention. To clarify the relationship between self-sampling
and the improvement for global health, such as cancer pre-
vention and infectious disease control, we conducted an
extensive literature review up to August 7, 2017. We used the
term self-sampling to search PubMed (http://www.ncbi.nlm.
nih.gov/pubmed), and a total of 259 published articles were
identified. It was interesting to discover that >90% of the
articles addressing self-sampling were related to sexual-related
diseases, such as cervical cancer screening. Furthermore,
nearly all of these articles discussed the value of the human
papillomavirus (HPV) test in cervical cancer screening. Sincesevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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cancer, it is believed that the detection of HPV is a good
alternative for cervical cancer screening. In addition, some
reports highlighted the proposition that HPV self-sampling is
easier to perform, less painful, less embarrassing, and less
anxiety provoking than the Pap smear. Of substantial impor-
tance is the fact that HPV self-sampling might increase cer-
vical cancer screening compliance for women who have never
before or not regularly been screened for cervical cancer.13
However, this concept may be applicable to western coun-
tries, but not appropriate in Taiwan. One recent study in Tai-
wan showed that the acceptability of self-sampling for HPV
test is still low, and only women who had a Pap test and
perceived themselves at high risk for cervical cancer are
willing to self-sample for HPV.14 Therefore, it may not be a
good strategy to suggest the use of self-sampling of pregnant
women for GBS screening, and we do not believe this sug-
gestion would encourage more pregnant women to receive
GBS screening.
In addition, as described in our previous comment about
GBS screening for pregnant women,15 in order to improve by
sufficient power a decrease in the false negative rate of GBS in
pregnant women, every pregnant women at gestational age
between 27 and 35 weeks would have to receive both culture
and polymerase chain reaction GBS screening methods; the
sampling sites would also need to include both anatomic sites
(rectum and low vagina). Although some studies consider the
similar effectiveness of GBS screening conducted by women
themselves or by their physicians,6 in a real-world practice, it
is hard to believe that pregnant women would prefer to per-
form these relatively complicated procedures themselves,
especially rectal sampling. As shown by a previous study,4
many obstetricians did not even perform the rectal and/or
vaginal sampling for GBS screening. Instead, these obstetri-
cians used perianal skin in place of the CDC recommended
sites. If the adherence to CDC guidelines is so substandard for
obstetricians, it is hard to believe that these pregnant women
are likely to have a superior adherence to the CDC guidelines
than their own medical providers. In conclusion, although the
study by Ko et al6 is interesting, their suggestion regarding
self-administered GBS screening might not be practical.
However, we welcome further inquiry to more compre-
hensively investigate this frequently debated issue.
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